Related Experiment Videos
Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction
J A Losman1, X P Chen, D Hilton
1Integrated Program in Molecular, Cellular, and Biophysical Studies, Department of Medicine, Columbia University, College of Physicians and Surgeons, New York 10032, USA.
Abstract:
IL-4 is an important regulator of the activation, proliferation, and differentiation of many hematopoetic cells. Many of these biological effects result from the activation of Janus kinases (JAK)1 and JAK3 and the transcription factor Stat6. Recent data suggest that members of the SOCS (suppressor of cytokine signaling) family of proteins can inhibit JAK-STAT signaling. We have examined the ability of SOCS family members to suppress IL-4 signaling, and we have found that SOCS-1 potently inhibits the activation of JAK1 kinase and Stat6 in response to IL-4. Furthermore, SOCS-1 can inhibit the induction of CD23 expression by IL-4. SOCS-2 does not inhibit induction of signaling by IL-4, while inhibition of IL-4 signaling by SOCS-3 can be detected in transient transfection systems, but not in stable cell lines. These studies implicate SOCS-1 in modulation of IL-4 signaling and suggest that SOCS-1 may play a role in regulating the immune response.
Insights
Suppressor of cytokine signaling-1 (SOCS-1) potently inhibits Interleukin-4 (IL-4) signaling by blocking Janus kinase (JAK) activation and Stat6 phosphorylation. This suggests SOCS-1 plays a key role in immune response regulation.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Interleukin-4 (IL-4) is crucial for hematopoetic cell development.
- IL-4 signaling involves Janus kinases (JAK) and the transcription factor Stat6.
- Suppressor of Cytokine Signaling (SOCS) proteins are known inhibitors of JAK-STAT pathways.
Purpose of the Study:
- To investigate the role of SOCS family members in suppressing IL-4 signaling.
- To determine which SOCS proteins effectively inhibit IL-4-induced JAK-STAT activation.
Main Methods:
- Examined the ability of SOCS-1, SOCS-2, and SOCS-3 to suppress IL-4 signaling.
- Assessed the inhibition of JAK1 kinase and Stat6 activation.
- Measured the induction of CD23 expression by IL-4.
Main Results:
- SOCS-1 potently inhibited IL-4-induced activation of JAK1 kinase and Stat6.
- SOCS-1 suppressed IL-4-mediated induction of CD23 expression.
- SOCS-2 showed no inhibition of IL-4 signaling, while SOCS-3 exhibited transient inhibition.
Conclusions:
- SOCS-1 is a potent inhibitor of IL-4 signaling.
- SOCS-1 plays a significant role in modulating IL-4-driven cellular responses.
- SOCS-1 may be a key regulator of immune responses mediated by IL-4.